Skip to content

To know the effect of Aralu(Ailanthus excelsa Roxb.) and Shyonaka(Oroxylum indicum Vent.) in the management of swelling

Evaluation of Shothahara karma of Aralu(Ailanthus excelsa Roxb.)as an alternative for Shyonaka(Oroxylum indicum Vent.) - Nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067401
Enrollment
30
Registered
2024-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R609- Edema, unspecified

Interventions

None listed

Sponsors

Nakum Payalben Ramjibhai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with the classical signs and symptoms of Shotha with less than 3 months of chronicity. 2.Shotha due to skin diseases, hypothyroidism, hypoproteinemia and generalized anasarca will be included.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from any systemic uncontrolled disease like Diabetes, hypertension, cardiac anomaly, Chronic renal failure, Liver cirrhosis, filariasis, etc. 2.Pregnant or lactating mother. 3.Patients exhibiting lakshanas of aagantuj Shotha. 4.Patients suffering from any auto immune diseases.

Design outcomes

Primary

MeasureTime frame
Improvement in condition will be assessed based on changes in scoring patterns developed for grading of these clinical factors. on 0th and 14th day. •Change in the clinical symptoms of General oedema pitting measurement of affected parts on 0th and 14th day. Timepoint: 2 weeks

Secondary

MeasureTime frame
Change in routine Blood & Urine investigations on 0th & 14th dayTimepoint: 14 day

Countries

India

Contacts

Public ContactNakum Payalben Ramjibhai

Institute for post graduate teaching and research in Ayurveda Jamnagar

brpayu@itra.edu.in7487876343

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026